Editorial: Results of the coronary drug project--an interpretation.
D002318:Cardiovascular Diseases / Q000401:mortality / Q000517:prevention & control*; D002986:Clinical Trials as Topic; D002994:Clofibrate / Q000627:therapeutic use; D004341:Drug Evaluation; D004967:Estrogens / Q000627:therapeutic use; D005500:Follow-Up Studies; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy*; D008297:Male; D009203:Myocardial Infarction / Q000150:complications; D009539:Nicotinic Acids / Q000627:therapeutic use; D010919:Placebos; D013974:Thyroxine / Q000627:therapeutic use; D014481:United States
D004967:Estrogens; D009539:Nicotinic Acids; D010919:Placebos; D002994:Clofibrate; D013974:Thyroxine